Redcare Pharmacy NV (SHPPF)
OTCMKTS
· Delayed Price · Currency is USD
148.22
0.00 (0.00%)
May 19, 2025, 4:00 PM EDT
Redcare Pharmacy NV Revenue
Redcare Pharmacy NV had revenue of 717.29M EUR in the quarter ending March 31, 2025, with 28.04% growth. This brings the company's revenue in the last twelve months to 2.53B, up 27.21% year-over-year. In the year 2024, Redcare Pharmacy NV had annual revenue of 2.37B with 31.79% growth.
Revenue (ttm)
2.53B EUR
Revenue Growth
+27.21%
P/S Ratio
1.07
Revenue / Employee
1.38M EUR
Employees
1,827
Market Cap
2.91B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.37B | 571.82M | 31.79% |
| Dec 31, 2023 | 1.80B | 594.41M | 49.35% |
| Dec 31, 2022 | 1.20B | 144.03M | 13.58% |
| Dec 31, 2021 | 1.06B | 92.26M | 9.53% |
| Dec 31, 2020 | 968.06M | 267.05M | 38.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 332.45M |
Redcare Pharmacy NV News
- 6 months ago - CTP Builds 30,000 sqm of Distribution Space for Redcare Pharmacy, Europe's Leading Online Pharmacy - Business Wire
- 6 months ago - Redcare Pharmacy NV (SAEYY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Redcare Pharmacy aims for higher 2024 sales after positive annual core earnings - Reuters